Scientific Board

  • Prof. Oliver Planz, Ph.D. (Chair)

    Universität D-Tübingen,Co-inventor of the technology, expert in antiviral research und translational preclinical R&D up to clinical studies. Advises the WHO on antiviral strategies against influenza.

  • Prof. Stephan Ludwig, Ph.D.

    Universität D-Münster, Co-inventor of the technology, globally renowned expert in influenza virus-cell interactions. Over 150 scientific publications and more than 10 patents.

  • Prof. Stephan Pleschka, Ph.D.

    Universität D-Gießen, Co-inventor of the technology. Expert in replication, infection and cell-virus interactions of the influenza virus. Advisor to biotech companies.

  • 1


Atriva Therapeutics GmbH
Christophstr. 32, 72072 Tübingen

+49 (0)7071 8597673